Leqembi, an Alzheimer's drug, offers hope for patients like Missie Meeks, diagnosed with early-stage Alzheimer's. Approved in July 2023, it helps extend normal life despite risks. The rollout faces challenges, but many believe the benefits outweigh the hurdles.